Interestingly, this TP53 activity-related gene signature differentiates well between TP53 functional retention and inactivation in BLCA and provides a more accurate and useful method for determining TP53 clinical value than TP53 mutation status alone. Here, TP53 is linked to bladder transitional cell carcinoma.